鄭英君

鄭英君

鄭英君，男，主任醫師，教授，廣州醫科大學博士生導師、博士後合作導師，廣州醫科大學附屬腦科醫院成人精神科科主任、學科帶頭人，廣州醫科大學精神衛生學院精神藥理學教研室主任。

基本介紹

  • 中文名：鄭英君
  • 國籍：中國
  • 學歷：日本醫學博士，精神病與精神衛生學博士後
  • 教學職稱：教授
  • 臨床職稱：主任醫師
  • 執業地點：廣州醫科大學附屬腦科醫院
  • 職業：精神科醫生
  • 專業：精神病學
出診信息,學術任職,個人經歷,獎勵榮譽,著作譯作,代表論文,

出診信息

芳村門診：星期二全天
荔灣門診：星期四全天

學術任職

廣州市醫師協會精神醫學分會主任委員
廣東省心理衛生協會重性心理障礙專業委員會主任委員
中國醫療保健國際交流促進會精神衛生分會委員
廣東省心理衛生協會常務理事
中華醫學會心身醫學分會心身重症醫學組委員
廣東省臨床醫學學會臨床心身醫學和心理治療專業委員會常委
廣東省醫師協會精神科分會委員
西部精神醫學協會重性精神障礙專業委員會委員
廣州市心理衛生協會常委
（華南地區精神心理科聯盟）華南精神病性障礙管理聯盟盟主
中華醫學會CSP精神分裂症協作組委員
中國醫師協會CPA精神分裂症凶鑽囑工作組委員

個人經歷

2008年畢業於日本國立Niigata University（新潟大學）醫學部，獲得日本國醫學博士學位
2008年-2009年任日本國立Niigata University腦研究所研究機關研究員炒霉舟、日本醫學博士後
2009年-2011年為中南大學湘雅二醫院精神衛生研究所精神病與精神衛生學博士後（出站）
現任廣州醫科大學附屬腦科醫院成人精神科科主任、學科帶頭人

獎勵榮譽

廣東省傑出青年醫學人才
廣州市醫學重點人才
入選廣東省《嶺南名醫錄》（2019）
好大夫線上全國“年度好大夫”獎
廣州市“羊城好醫生”獎

著作譯作

主編《精神分裂症的疾病管理與康復技術》（人民衛生出版社，2019年）
副主編《精神分裂症》（人民衛生出版社，2012年）
參編《中國失眠防治指南》、《精神病汗霉堡諒學新進展》及《精神病學》等7部專著

代表論文

  1. She S, Deng Y, Chen Y, Wu C, Yi W, Lu X, Chen X, Ni J, Li R, Zhang J, Xiao D, Ning Y, Zheng Y*(鄭英組整宙君，通訊作者). Two-stage integrated care versus antipsychotic medication alone on outcomes of schizophrenia: One-year randomized controlled trial and follow-up. Psychiatry Research. 2017 Apr 25.
  2. She S, Li H, Ning Y, Ren J, Wu Z, Huang R, Zhao J, Wang Q, Zheng Y*(鄭英汗府盼催君，通訊作者). Revealing the Dysfunction of Schematic Facial-Expression Processing in Schizophrenia: A Comparative Study of Different References. Frontiers in Neuroscience. 2017;11.
  3. She S, Yi W, Zhang B, Zheng Y*(鄭英君，通榆戶訊作者). Worsening of myasthenia gravis after administration of antipsychotics for treatment of schizophrenia: A case report and review of literature. Journal of Clinical Psychopharmacology. 2017.
  4. She S, Zhang B, Zheng Y*(鄭英君，通訊作者). Face-related visual search deficits in first-episode schizophrenia. Psychiatry Research. (Accepted)
  5. Wu C#, Zheng Y#(鄭英君，並列第一作者), Li J, Wu H, She S, Liu S, Ning Y, Li L. Brain substrates underlying auditory speech priming in healthy listeners and listeners with schizophrenia. Psychological medicine. 2017 Apr;47(5):837-52.
  6. Zheng Y（鄭英地漿才君), Wu C, Li J, Wu H, She S, Liu S, Mao L, Ning Y, Li L. Brain substrates of perceived spatial separation between speech sources under simulated reverberant listening conditions in schizophrenia. Psychological medicine. 2016 Feb 1;46(03):477-91.
  7. Zheng Y, Li H, Ning Y, Ren J, Wu Z, Huang R, Luan G, Li T, Bi T, Wang Q, She S. Sluggishness of Early-Stage Face Processing (N170) Is Correlated with Negative and General Psychiatric Symptoms in Schizophrenia. Frontiers in Human Neuroscience. 2016;10.
  8. Zheng W#, Zheng YJ#(鄭英君，並列第一作者), Li XB, Tang YL, Wang CY, Xiang YQ, de Leon J. Efficacy and Safety of Adjunctive Aripiprazole in Schizophrenia: Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Psychopharmacology. 2016 Dec 1;36(6):628-36.
  9. Zhu F#, Zheng Y#(鄭英君，並列第一作者), Liu Y, Zhang X, Zhao J. Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic–polyribocytidilic acid. Psychiatry research. 2014 Nov 30;219(3):680-6.
  10. Zhu F#, Zheng Y#(鄭英君，並列第一作者), Ding YQ, Liu Y, Zhang X, Wu R, Guo X, Zhao J. Minocycline and risperidone prevent microglia activation and rescue behavioral deficits induced by neonatal intrahippocampal injection of lipopolysaccharide in rats. PloS one. 2014 Apr 4;9(4):e93966.
  11. Zhu F, Liu Y, Zhao J, Zheng Y*(鄭英君，通訊作者). Minocycline alleviates behavioral deficits and inhibits microglial activation induced by intrahippocampal administration of Granulocyte–Macrophage Colony-Stimulating Factor in adult rats. Neuroscience. 2014 Apr 25;266:275-81.
  12. Zhu F, Zhang L, Ding YQ, Zhao J, Zheng Y*(鄭英君，通訊作者). Neonatal intrahippocampal injection of lipopolysaccharide induces deficits in social behavior and prepulse inhibition and microglial activation in rats: Implication for a new schizophrenia animal model. Brain, behavior, and immunity. 2014 May 31;38:166-74.
  13. Zheng Y（鄭英君）, Watakabe A, Takada M, Kakita A, Namba H, Takahashi H, Yamamori T, Nawa H. expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):701-6.
  14. Zheng Y（鄭英君）, Sudou K, Nawa H, Namba H. Field potential recording in the ventral tegmental area: pharmacological and toxicological evaluations of postsynaptic dopaminergic neuron activity. Neurosci Res. 2006 Aug;55(4):426-33.
  15. Mizuno M, Sotoyama H, Narita E, Kawamura H, Namba H, Zheng Y（鄭英君）, Eda T, Nawa H.A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor. J Neurosci. 2007 Sep 19;27(38):10116-27.
  16. Namba H, Zheng Y（鄭英君）, Abe Y, Nawa H.Epidermal growth factor administered in the periphery influences excitatory synaptic inputs onto midbrain dopaminergic neurons in postnatal mice. Neuroscience. 2009 Feb 18;158(4):1731-41.
  17. Abe Y, Namba H, Zheng Y（鄭英君）, Nawa H. Neuroscience. In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. 2009 Jun 16;161(1):95-110.
  18. Tohmi M, Tsuda N, Zheng Y(鄭英君), Mizuno M, Sotoyama H, Shibuya M, Kawamura M, Kakita A, Takahashi H, Nawa H.The cellular and behavioral consequences of interleukin-1 alpha penetration through the blood-brain barrier of neonatal rats: a critical period for efficacy. Neuroscience. 2007 Nov 30;150(1):234-50.
  19. Sotoyama H, Zheng Y（鄭英君), Iwakura Y, Mizuno M, Aizawa M, Shcherbakova K, Wang R, Namba H, Nawa H. Pallidal hyperdopaminergic innervation underlying d2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF. PLoS One. 2011;6(10)
  20. Iwakura Y, Zheng Y（鄭英君), Sibilia M, Abe Y, Piao YS, Yokomaku D, Wang R, Ishizuka Y, Takei N, Nawa H. Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1). J Neurochem. 2011 Jul;118(1):45-56.
  21. Mizuno M, Iwakura Y, Shibuya M, Zheng Y（鄭英君), Eda T, Kato T, Takasu Y, Nawa H. Antipsychotic potential of quinazoline ErbB1 inhibitors in a schizophrenia model established with neonatal hippocampal lesioning. J Pharmacol Sci. 2010;114(3):320-31. Epub 2010 Oct 14.
  22. Ryufuku M, Toyoshima Y, Kitaura H, Zheng Y（鄭英君), Fu YJ, Miyahara H, Murakami H, Masuda H, Kameyama S, Takahashi H, Kakita A. Hypertrophy of hippocampal end folium neurons in patients with mesial temporal lobe epilepsy. Neuropathology. 2011 Oct;31(5):476-85.
  23. Hu M, Chen J, Li L, Zheng Y（鄭英君), Wang J, Guo X, Wu R, Zhao J. Semantic fluency and executive functions as candidate endophenotypes for the early diagnosis of schizophrenia in Han Chinese. Neurosci Lett. 2011 Sep 20;502(3):173-7.
  24. Liu F, Guo X, Wu R, Ou J, Zheng Y, Zhang B, Xie L, Zhang L, Yang L, Yang S, Yang J, Ruan Y, Zheng Y（鄭英君）, Xu X, Zhao J. Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial. Schizophr Res. 2014 Mar;153(1-3):169-76.
  25. Miyahara H, Natsumeda M, Shiga A, Aoki H, Toyoshima Y, Zheng Y（鄭英君）, Takeuchi R, Murakami H, Masuda H, Kameyama S, Izumi T, Fujii Y, Takahashi H, Kakita A. Suppressed expression of autophagosomal protein LC3 in cortical tubers of tuberous sclerosis complex. .Brain Pathol. 2013 May;23(3):254-62.
  26. She S,Zhang B,Mi L,Li H,Kuang Q,Bi T,Zheng Y（鄭英君，通訊作者）， Stimuli may have little impact on the deficit of visual working memory accuracy in first-episode schizophrenia. Neuropsychiatr Dis Treat.，2019 Feb 18;15:481-489.
  27. Wu C,Zheng Y（鄭英君，並列第一）Li J,She S,Peng H,Li L Cortical Gray Matter Loss, Augmented Vulnerability to Speech-on-Speech Masking, and Delusion in People With Schizophrenia. Front Psychiatry.2018 Jul 4;9:287. doi: 10.3389/fpsyt.2018.00287. eCollection 2018.
  28. Zheng Y(鄭英君)，Wu C,Li J,Li R,Peng H,She S,Ning Y,Li L. Schizophrenia alters intra-network functional connectivity in the caudate for detecting speech under informational speech masking conditions. BMC Psychiatry.2018 Apr 4;18(1):90.
  29. Zheng Y（鄭英君），Ning Y,She S,Deng Y,Chen Y,Yi W,Lu X,Chen X,Li J,Li R,Zhang J,Xiao D,Wu H,Wu C. Psychotic Symptoms and Attitudes toward Medication Mediate the Effect of Insight on Personal-Social Functions in Patients with Schizophrenia: One-Year Randomized Controlled Trial and Follow-Up. Psychopathology.2018;51(3):167-176.
  30. Xie P,Wu K,Zheng Y（鄭英君）,Guo Y,Yang Y,He J,Ding Y,Peng H. Prevalence of childhood trauma and correlations between childhood trauma, suicidal ideation, and social support in patients with depression, bipolar disorder, and schizophrenia in southern China. J Affect Disord.2018 Mar 1;228:41-48.
  31. She S,Kuang Q,Zheng Y.(鄭英君，通訊作者) Aripiprazole-induced tardive dyskinesia in patients with schizophrenia: A case report of twins. Schizophr Res.2017 Nov 8.
  32. Li J,Wu C,Zheng Y（並列第一作者），Li R,Li X,She S,Wu H,Peng H,Ning Y,Li L. Schizophrenia affects speech-induced functional connectivity of the superior temporal gyrus under cocktail-party listening conditions. Neuroscience.2017 Sep 17;359:248-257.
  33. Dai J,Du X,Yin G,Zhang Y（鄭英君）,Xia H,Li X,Cassidy R,Tong Q,Chen D,Teixeira AL,Zheng Y,Ning Y,Soares JC,He MX,Zhang XY. Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naïve patients with schizophrenia presenting with first episode psychosis. Schizophr Res.2018 Mar;193:182-187.

相關詞條

熱門詞條

聯絡我們